Biogen | BIIB - Trade Debtors



Biogen reported $2.08B in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
AbbVie USD 12.48B 1.56B Mar/2025
Acadia Pharmaceuticals USD 119.69M 5.97M Jun/2025
ALKERMES USD 356.33M 34.58M Jun/2025
Amgen USD 8.7B 569M Jun/2025
Bayer EUR 17.64B 895M Jun/2025
Biogen USD 2.08B 87.5M Jun/2025
BioMarin Pharmaceutical USD 855.85M 116.68M Jun/2025
Bristol-Myers Squibb USD 15.1B 515M Jun/2025
Eli Lilly USD 17.21B 3.2B Jun/2025
Gilead Sciences USD 4.78B 393M Jun/2025
Incyte USD 842.89M 19.76M Jun/2025
Merck USD 12.72B 1.14B Jun/2025
Moderna USD 457M 151M Jun/2025
Neurocrine Biosciences USD 595.7M 79.7M Jun/2025
Novartis USD 9.18B 451M Jun/2025
Pfizer USD 16.09B 1.35B Jun/2025
PTC Therapeutics USD 196.13M 14.36M Jun/2025
Regeneron Pharmaceuticals USD 5.61B 49M Jun/2025
Sanofi 8.21B 7.76B Jun/2025
Sanofi 8.21B 2.42B Jun/2025
Sarepta Therapeutics USD 609.6M 114.93M Jun/2025
Teva Pharmaceutical Industries USD 3.56B 180M Jun/2025
Ultragenyx Pharmaceutical USD 124.46M 25.62M Jun/2025
United Therapeutics USD 379.3M 57.3M Jun/2025
Vertex Pharmaceuticals USD 1.89B 88.4M Jun/2025